Safety Concerns Linked to Herbal Medicine Use in Cancer
Concerns include altered pharmacodynamics, direct toxic effects, increased chemosensitivity
November 2015 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2015. This roundup includes...
RSNA: Breast Cancer Screening Among Poor Up Post ACA
Researchers report that expansion of Medicaid coverage is improving access to mammograms
Telephone Counseling Benefits Overweight Breast CA Survivors
Telephone counseling is similarly effective to in-person counseling for breast cancer survivors
FDA Approves Empliciti for Multiple Myeloma
Monoclonal antibody works with another approved therapy to provide additional benefit
Impact of Recurrence Score Assay Varies With Patient Age
For women with early-stage breast cancer, testing lowers chemo use, costs among women <55 years
Early-Stage Cervical CA Diagnoses in Young Women Up Since ACA
Provision allowing young adults to stay on parents' insurance may account for more screening
FDA Approves Portrazza for Advanced Squamous NSCLC
Drug is designed to block activity of epidermal growth factor receptor protein
AAFP Recommends Doctors Explore Use of Social Media
Guidelines provided for physicians wishing to become more active in social media
ACP: Physicians Should Prescribe Generic Meds If Possible
Brand name medications not superior to molecularly identical generic medications
